These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30005134)

  • 1. A practical application of onychomycosis cure - combining patient, physician and regulatory body perspectives.
    Gupta AK; Versteeg SG; Shear NH
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):281-287. PubMed ID: 30005134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo cure rates in the treatment of onychomycosis.
    Gupta AK; Paquet M
    J Am Podiatr Med Assoc; 2014 May; 104(3):277-82. PubMed ID: 24901587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for cure following treatment of onychomycosis.
    Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):679-84. PubMed ID: 19929941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives.
    Gupta AK; Studholme C
    J Dermatolog Treat; 2016 Nov; 27(6):498-504. PubMed ID: 27043266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on current approaches to diagnosis and treatment of onychomycosis.
    Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V
    Expert Rev Anti Infect Ther; 2018 Dec; 16(12):929-938. PubMed ID: 30411650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis: Does Cure Equate to Treatment Success?
    Elewski BE; Gupta AK; Rosen T; Caldwell BD; Pariser DM; Kircik LH; Bhatia N; Tosti A
    J Drugs Dermatol; 2016 May; 15(5):626-32. PubMed ID: 27168271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
    Iozumi K; Abe M; Ito Y; Uesugi T; Onoduka T; Kato I; Kato F; Kodama K; Takahashi H; Takeda O; Tomizawa K; Nomiyama T; Fujii M; Mayama J; Muramoto F; Yasuda H; Yamanaka K; Sato T; Oh-I T; Kasai H; Tsuboi R; Hattori N; Maruyama R; Omi T; Shimoyama H; Sei Y; Nakasu I; Nishimoto S; Hata Y; Mochizuki T; Fukuzawa M; Seishima M; Sugiura K; Katayama I; Yamamoto O; Shindo M; Kiryu H; Kusuhara M; Takenaka M; Watanabe S
    J Dermatol; 2019 Aug; 46(8):641-651. PubMed ID: 31206779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.
    Gupta AK; Versteeg SG; Shear NH; Piguet V; Tosti A; Piraccini BM
    Am J Clin Dermatol; 2019 Feb; 20(1):123-133. PubMed ID: 30456537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. British Association of Dermatologists' guidelines for the management of onychomycosis 2014.
    Ameen M; Lear JT; Madan V; Mohd Mustapa MF; Richardson M
    Br J Dermatol; 2014 Nov; 171(5):937-58. PubMed ID: 25409999
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure.
    Gupta AK; Daigle D; Paquet M
    J Am Podiatr Med Assoc; 2015 Jul; 105(4):357-66. PubMed ID: 25032982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of toe onychomycosis: what is the potential for improving efficacy of treatment?
    Gupta AK
    Clin Dermatol; 2002; 20(5):607-9. PubMed ID: 12435532
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical challenge of onychomycosis.
    Meehan KJ; Miller C
    JAAPA; 2001 Apr; 14(4):43-6, 49-50. PubMed ID: 11521365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Today's treatments options for onychomycosis.
    Iorizzo M; Piraccini BM; Tosti A
    J Dtsch Dermatol Ges; 2010 Nov; 8(11):875-9. PubMed ID: 20738460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Cure Rates in Onychomycosis.
    Gupta AK; Cernea M; Foley KA
    J Cutan Med Surg; 2016 Nov; 20(6):517-531. PubMed ID: 27313230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis--treatment, relapse and re-infection.
    Hull PR
    Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Onychomycosis].
    Sato T
    Med Mycol J; 2016; 57(4):J171-J173. PubMed ID: 27904063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.